ASCI / Young Physician-Scientist Awards, 2023

The Young Physician-Scientist Awards (YPSA) recognize physician-scientists who are early in their first faculty appointment and have made notable achievements in their research.

View all ASCI awards

Jessica E. Manning, MD, MSc
National Institutes of Health
(Affiliation at the time of recognition)

About the awardee

Jessica E. Manning, MD, MSc is an infectious diseases physician-scientist who directs the International Center of Excellence in Research CAMBODIA, a research collaboration between the Cambodian Ministry of Health and the US National Institute of Allergy and Infectious Diseases, in Phnom Penh, Cambodia. Dr. Manning began her clinical research career studying malaria as an NIH Fogarty International Clinical Research Fellow in Mali, West Africa.  After graduating from Emory University School of Medicine, she completed the Doris and Howard Hiatt Residency in Global Health Equity and Internal Medicine at Brigham and Women’s Hospital and her Infectious Diseases fellowship training at the National Institute of Allergy and Infectious Diseases. She also holds a Masters degree in Epidemiology from the Harvard School of Public Health. Since 2013, she has spent most of her time in Southeast Asia focused initially on treatment regimens for multidrug-resistant malaria, and more recently, on understanding arboviral epidemics and developing better tools to mitigate them.  In 2017, she re-located to Cambodia to further NIAID’s mission of conducting international translational and clinical research related to vector-borne and other emerging pathogens followed by her appointment as a NIAID Assistant Clinical Investigator in 2019. Her research aims encompass both: 1) characterization of the host immune response to mosquito saliva and arboviruses in order to develop vector-based countermeasures to vector-borne disease epidemics; and 2) application of pathogen metagenomics in resource-scarce, outbreak-prone areas to better understand disease transmission of vector-borne and emerging pathogens.